EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Yongchao Dou, Lizabeth Katsnelson, Marina A Gritsenko, Yingwei Hu, Boris Reva, Runyu Hong, Yi-Ting Wang, Iga Kolodziejczak, Rita Jui-Hsien Lu, Chia-Feng Tsai, Wen Bu, Wenke Liu und 48 weitere

Cancer Cell · 2023-09 · 41 (9) · 1586-1605.e15

DOI: 10.1016/j.ccell.2023.07.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2023-09. Verfasst von Yongchao Dou und 59 weiteren Autor:innen. Beteiligte Einrichtung: Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of…. Hauptthemen laut MEDLINE: Proteogenomics, Endometrial Neoplasms, Metformin. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We characterized a prospective endometrial carcinoma (EC) cohort containing 138 tumors and 20 enriched normal tissues using 10 different omics platforms. Targeted quantitation of two peptides can predict antigen processing and presentation machinery activity, and may inform patient selection for immunotherapy. Association analysis between MYC activity and metformin treatment in both patients and cell lines suggests a potential role for metformin treatment in non-diabetic patients with elevated MYC activity. PIK3R1 in-frame indels are associated with elevated AKT phosphorylation and increased sensitivity to AKT inhibitors. CTNNB1 hotspot mutations are concentrated near phosphorylation sites mediating pS45-induced degradation of β-catenin, which may render Wnt-FZD antagonists ineffective. Deep learning accurately predicts EC subtypes and mutations from histopathology images, which may be useful for rapid diagnosis. Overall, this study identified molecular and imaging markers that can be further investigated to guide patient stratification for more precise treatment of EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteogenomicsEndometrial NeoplasmsMetforminFemaleHumansProto-Oncogene Proteins c-aktProspective Studiesbeta Catenin

Stichwörter der Autor:innen

CPTACCTNNB1PIK3R1deep learningendometrial cancermetforminproteogenomicstarget assays

Substanzen

Proto-Oncogene Proteins c-aktbeta CateninMetformin

Autor:innen und Institutionen

  • Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Dan L Duncan Comprehensive Cancer C…
  • Institute for Systems Genetics, NYU Grossman School of Medicine, New York, NY 10016, USA; Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.
  • Department of Pathology and Oncology, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • International Institute for Molecular Oncology, 20-203 Poznań, Poland; Postgraduate School of Molecular Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.

Förderung

  • NCI NIH HHS
  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • U.S. Department of Defense
  • Pacific Northwest National Laboratory
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health
  • U.S. Department of Energy

Zitieren

APA

Dou, Y., Katsnelson, L., Gritsenko, M. A., Hu, Y., Reva, B., Hong, R., Wang, Y. T., Kolodziejczak, I., Lu, R. J., Tsai, C. F., Bu, W., Liu, W., Guo, X., An, E., Arend, R. C., Bavarva, J., Chen, L., Chu, R. K., Czekański, A., …, & Robles, A. I. (2023). Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer Cell, 41(9), 1586-1605.e15. https://doi.org/10.1016/j.ccell.2023.07.007

Vancouver

Dou Y, Katsnelson L, Gritsenko MA, Hu Y, Reva B, Hong R, et al. Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer Cell. 2023;41(9):1586-1605.e15. doi:10.1016/j.ccell.2023.07.007

BibTeX
@article{Dou2023,
  author = {Dou, Yongchao and Katsnelson, Lizabeth and Gritsenko, Marina A and Hu, Yingwei and Reva, Boris and Hong, Runyu and Wang, Yi-Ting and Kolodziejczak, Iga and Lu, Rita Jui-Hsien and Tsai, Chia-Feng and Bu, Wen and Liu, Wenke and Guo, Xiaofang and An, Eunkyung and Arend, Rebecca C and Bavarva, Jasmin and Chen, Lijun and Chu, Rosalie K and Czekański, Andrzej and Davoli, Teresa and Demicco, Elizabeth G and DeLair, Deborah and Devereaux, Kelly and Dhanasekaran, Saravana M and Dottino, Peter and Dover, Bailee and Fillmore, Thomas L and Foxall, McKenzie and Hermann, Catherine E and Hiltke, Tara and Hostetter, Galen and Jędryka, Marcin and Jewell, Scott D and Johnson, Isabelle and Kahn, Andrea G and Ku, Amy T and Kumar-Sinha, Chandan and Kurzawa, Paweł and Lazar, Alexander J and Lazcano, Rossana and Lei, Jonathan T and Li, Yi and Liao, Yuxing and Lih, Tung-Shing M and Lin, Tai-Tu and Martignetti, John A and Masand, Ramya P and Matkowski, Rafał and McKerrow, Wilson and Mesri, Mehdi and Monroe, Matthew E and Moon, Jamie and Moore, Ronald J and Nestor, Michael D and Newton, Chelsea and Omelchenko, Tatiana and Omenn, Gilbert S and Payne, Samuel H and Petyuk, Vladislav A and Robles, Ana I},
  title = {Proteogenomic insights suggest druggable pathways in endometrial carcinoma},
  journal = {Cancer Cell},
  year = {2023},
  volume = {41},
  number = {9},
  pages = {1586--1605.e15},
  doi = {10.1016/j.ccell.2023.07.007}
}
Kostenlos starten →